Reach Us +44 3308 085114
C9ORF72 Repeat Expansion Bioinformatics Analysis In A Brazilian Cohort Of Amyotrophic Lateral Sclerosis | 45854
ISSN: 2157-7420

Journal of Health & Medical Informatics
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

C9ORF72 Repeat Expansion bioinformatics analysis in a Brazilian cohort of Amyotrophic Lateral Sclerosis

3rd International Conference on Health Informatics and Technology

Gerson Chadi, Callegaro, Camila Galvao Lopes, Samantha Nakamura dos Santos, Gabriela Natania Sales Rebelo, Jessica Ruivo Maximino, Joyce Meire Gilio, Fabrício Castro de Borba, Frederico M de Haidar Jorge and Dagoberto

University of São Paulo School of Medicine, São Paulo, Brazil

Posters & Accepted Abstracts: J Health Med Inform

DOI: 10.4172/2157-7420.C1.010

Amyotrophic Lateral Sclerosis (ALS) is a fast progression motor neuron degenerative disease. Genetic mutations are the unique defined risk factors for Familial forms (FALS) of ALS. The risk factors for Sporadic forms (SALS) of the disease are still unknown, despite the presence of specific mutations in those patients. Advances in technology and bioinformatics analyses have contributed to identify mutations and also to understand the relationship among genotypes and phenotypes of ALS patients. The expanded GGGGCC hexanucleotide repeats in C9ORF72 gene is the most prevalent genetic mutation in FALS in USA and Europe. The aim of this study was to investigate the frequency of C9ORF72 repeat expansions in a cohort of Brazilian ALS patients and also to evaluate the number of repeats, employing advanced bioinformatics methods. FALS (39) and in SALS (189) patients from the Research Center of the Clinics Hospital of the University of São Paulo School of Medicine, in Brazil, were evaluate. A repeat-primed polymerase chain reaction (PCR) amplification was performed on a genetic analyzer. The electropherograms were interpreted using a semiautomatic informatics analysis, which was accomplished by means of two different sampled panels as reference. In the first analysis, the fluorescence peaks were identified by a specific software based on a built-in digital panel. The second analysis was based on a digital panel that was created using proportional representative samples of all previously genotyped ALS patients. This panel was then composed by 2 patients with C9ORF72 repeat-expansion (more than 31 repeats), 1 patient with a borderline number of repeats (between 20 and 30 repeats) and 47 with less than 20 repeats. Peaks with a 6-base-pair periodicity were counted in both analyses. A cutoff of >30 repeats combined with a decrementing saw-tooth pattern was considered as pathological repeat-expansion. Patients who have had up to 20 repeats were considered non-pathogenic, while those who presented 21 to 30 repeats were classified as intermediate group. Differences between the two methods were compared using a two-tailed unpaired t-test. C9ORF72 repeat expansions were identified in 5 FALS (12.8%) and 5 SALS (2.64%). Patients with repeat expansions had more than 54 repeats, 4 patients had 21- 30 repeats and 214 patients had less than 21 repeats. There was no difference between the two applied methods. C9ORF72 repeat expansions were found in FALS and SALS patients. Both bioinformatics analyses seemed suitable for the C9ORF72 repeat expansion diagnosis. FUNDING: This work was supported by FAPESP and CNPq, Brazil.

The authors, which have equal contribution to the work, belong to the Neuroregeneration Center of the Department of Neurology of the University of Sao Paulo Medical School, Brazil. The Center was stablished in 2006 and it is composed by students, post doctoral, post doctorates, biologists, molecular biologists, bioinformatics, physiotherapists, speech therapists, psychologists, physicians and clinicians interested to perform translational neurology and clinical neurology research in the field of neurodegenerative disorders. The group is headed by Professor Gerson Chadi, MD. PHD., Full Professor of the Department. The Group has put a great effort on the mechanisms of neuronal degeneration of Amyotrophic Lateral Sclerosis (ALS) by developing Translational Neurology Projects (bench to bed), being responsible for various clinical and laboratory studies. The Group members have published important papers in the most prestigious journals in the field.

Email: [email protected]